Charles Schwab Investment Management Inc Vista Gen Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$0.12 - $0.3 $7,989 - $19,974	66,581 Added 15.56%	494,520 $59,000
Q3 2022 Nov 14, 2022	SELL	$0.14 - $4.8 $15,793 - $541,478	-112,808 Reduced 20.86%	427,939 $66,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $10,959 - $21,545	-12,454 Reduced 2.25%	540,747 $476,000
Q1 2022 May 13, 2022	BUY	$1.14 - $2.09 $77,273 - $141,668	67,784 Added 13.96%	553,201 $686,000
Q4 2021 Feb 11, 2022	BUY	$1.67 - $2.76 $522 - $863	313 Added 0.06%	485,417 $947,000
Q3 2021 Nov 16, 2021	BUY	$2.62 - $3.45 $28,146 - $37,063	10,743 Added 2.26%	485,104 $1.33 Million
Q2 2021 Aug 16, 2021	BUY	$1.96 - $3.15 $832,184 - $1.34 Million	424,584 Added 852.97%	474,361 $1.5 Million
Q1 2021 May 17, 2021	BUY	$1.89 - $2.96 $94,078 - $147,339	49,777 New	49,777 $107,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $517M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.